You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is Micro dosing studies done in w hich ph ase of clinical triais- and explain in detail?
Ans. is 'a' i.e., 0 [Ref: K D Tripathi 7th/ep. 73 - 75, style="font-size: 1.04761904761905em; font-family: Times New Roman, Times, serif; margin: 0 0 8pt 4px; text-indent: 0; text-align: left">Phase 0 - Microdosing strategy in clinical trialso Drug development is an activity that is long, complex and expensive.o In 2004, attrition in the drug development paradigm prompted the US Food and Drug Administration (FDA) to introduce its "Critical Path" document, which highlighted the serious discordance between major scientific advances and limited drug development process.o One issue addressed was that of microdosing.o The concept of microdosing involves the use of extremely low, nonpharmacoiogically active doses of a drug to define the pharmacokinetic profile of the medication in human subjects.o Microdosing, thus, appears as a new viable concept in the "toolbox' of the drug development activity.o It is included in the phase 0 of the drug clinical trial.